180 Life Sciences Corp. Acquisition Posted on October 30, 2024 by David Loev In October 2024, represented 180 Life Sciences Corp. in the acquisition of source code and intellectual property relating to an online blockchain casino and regaining compliance with Nasdaq minimum stockholders’ equity